ストックスクリーナーアプリを入手
43.10
4.14%
-1.86
アフターアワーズ：
43.28
0.18
+0.42%
Boston Scientific Corp (BSX) 最新ニュース
Alpha Buying: 4 Falling Knives Insiders Are Buying - Benzinga
Boston Scientific stock falls as cyberattack clouds 2026 guidance - ad-hoc-news.de
Boston Scientific at Wells Fargo conference: cyberattack clouds outlook - Investing.com
Update on recent cybersecurity incident - Boston Scientific
Boston Scientific stock falls as cyberattack prompts guidance cut and BTIG lowers price target - ad-hoc-news.de
Boston Scientific Flags Financial Hit From Cyberattack - BankInfoSecurity
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors? - The Motley Fool
Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
BSX Maintains Buy Rating by BTIG -- Price Target Lowered to $56 - GuruFocus
Boston Scientific says cyberattack likely to hurt 2026 sales, profit By Reuters - Investing.com
Boston Scientific Corp (BSX) Stock Down 5.9% -- Now Undervalued? GF Score: 77/100 - GuruFocus
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack - theinsurer.com
Boston Scientific Flags Guidance Miss Amid 'Material Impact' From Cybersecurity Incident; Shares Fall - Yahoo! Finance Canada
Boston Scientific misses 2026 guidance after cyberattack - Yahoo Finance
Boston Scientific Says Cyberattack Will Impact 2026 Results — Says It Is ‘Unlikely’ To Meet Net Sales Growth, EPS Guidance Ranges - Yahoo Finance
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack - Benzinga
Boston Scientific stock falls after 2026 guidance cut - AD HOC NEWS
Damages from med-tech cyberattacks adding up - BioWorld News
Boston Scientific left nursing its bottom line after cyberattack - The Register
Boston Scientific Unlikely to Meet Forecasts After Cyber Attack - Bloomberg.com
Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers - Yahoo Finance
Boston Scientific Warns On Earnings After Cyberattack - baystreet.ca
Boston Scientific Says Cyberattack Will Hit Q3 and FY2026 Results and Miss Guidance - Minichart
Boston Scientific Shares Slide After Cyberattack Forces 2026 Guidance Cut - AskTraders
Boston Scientific's 2026 Growth Outlook Weakens: Is Recovery Ahead? - Yahoo Finance
Boston Scientific unlikely to meet guidance due to cyberattack - Yahoo Finance
TD Cowen reiterates Boston Scientific stock Buy rating after cyber recovery By Investing.com - Investing.com South Africa
Boston Scientific Unlikely to Meet Net Sales Guidance as Cybersecurity Incident Disrupts Operations - marketscreener.com
Boston Scientific CorpIdentifies Cybersecurity Incident Causing Global Operational DisruptionSEC Filing - TradingView
Boston Scientific Won't Meet Guidance Due to Cyberattack - marketscreener.com
Boston Scientific unlikely to meet Q3FY26 and full-year guidance - scanx.trade
Boston Scientific Won’t Meet Guidance Due to Cyberattack - Yahoo Finance
Why is Boston Scientific stock sliding today? - Investing.com
Why is Boston Scientific stock sliding today? By Investing.com - Investing.com UK
Boston Scientific says cyberattack likely to hurt 2026 sales, profit - marketscreener.com
Boston Scientific says cyberattack likely to hurt 2026 sales, profit targets - marketscreener.com
Cyberattack forces Boston Scientific (NYSE: BSX) to rethink its 2026 outlook - Stock Titan
TD Cowen reiterates Boston Scientific stock Buy rating after cyber recovery - Investing.com Canada
Boston Scientific on road to recovery following cyberattack - Yahoo Finance
Boston Scientific stock holds steady as investors weigh latest medical-device growth story - ad-hoc-news.de
Boston Scientific stock gains support from institutional buying and solid Q2 2026 results - AD HOC NEWS
Recall Recap: Boston Scientific Pacemakers, Baby Formula - Law360
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
TD Cowen reiterates Boston Scientific stock rating on shipping restoration - Investing.com
Boston Scientific Recalls Spinal Cord Stimulator Leads Over Fracture Risk - Benzinga
Renal Denervation Market Size, Share & Trends Analysis - GlobeNewswire Inc.
Boston Scientific (NYSE:BSX) Trades Below Its Cash-Flow Value - Kalkine Media
Boston Scientific's ICVT Business Gains Momentum: Can Growth Continue? - Yahoo Finance
Boston Scientific Corp Stock Price Live, Charts & News - economictimes.indiatimes.com
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Boston Scientific (BSX) Could Be 23% Undervalued After Recalls And Cyber Incident - Yahoo Finance
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Boston Scientific (BSX) Issues Multiple Worldwide Product Recalls - Yahoo Finance
Vanguard PRIMECAP Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (NYSE:BSX) Closes In on Its Landmark Penumbra Deal - kalkinemedia.com
How Is Boston Scientific's Stock Performance Compared to Other Medical Device Stocks? - Barchart.com
Boston Scientific (NYSE: BSX) EVP’s 1,171-share award partly withheld for taxes - Stock Titan
Boston Scientific options surge signals institutional bet on year-end recovery - Investing.com
Healthcare cyberattacks hit pacemakers and millions of patient records - theregister.com
0.68%
1.43%
大文字化:
|
ボリューム (24 時間):